欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7152/001
药品名称Azelastine/Fluticasone Viatris Nasal Spray 137 micrograms/50 micrograms per actuation Nasal Spray, Suspension
活性成分
    • Azelastine hydrochloride 137.0 µg
    • Fluticasone propionate 50.0 µg
剂型Nasal spray, suspension
上市许可持有人Viatris Healthcare GmbH Lütticher Straße 5 53842 Troisdorf Germany
参考成员国 - 产品名称Germany (DE)
Azelastin/Fluticason Viatris 137 Mikrogramm/50 Mikrogramm pro Sprühstoß Nasenspray, Suspension
互认成员国 - 产品名称
    • Netherlands (NL)
    • Romania (RO)
      AZEFLU 137 micrograme / 50 micrograme spray nazal, suspensie
    • Austria (AT)
    • Slovakia (SK)
    • France (FR)
    • Slovenia (SI)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Azeflu
    • Hungary (HU)
    • Denmark (DK)
    • Czechia (CZ)
      Azeflu
许可日期2023/03/15
最近更新日期2024/10/25
药物ATC编码
    • R01AD58 fluticasone, combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase